Predicting postoperative neurological outcomes of degenerative cervical myelopathy based on machine learning.

IF 4.3 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Frontiers in Bioengineering and Biotechnology Pub Date : 2025-03-04 eCollection Date: 2025-01-01 DOI:10.3389/fbioe.2025.1529545
Shuai Zhou, Zexiang Liu, Haoge Huang, Hanxu Xi, Xiao Fan, Yanbin Zhao, Xin Chen, Yinze Diao, Yu Sun, Hong Ji, Feifei Zhou
{"title":"Predicting postoperative neurological outcomes of degenerative cervical myelopathy based on machine learning.","authors":"Shuai Zhou, Zexiang Liu, Haoge Huang, Hanxu Xi, Xiao Fan, Yanbin Zhao, Xin Chen, Yinze Diao, Yu Sun, Hong Ji, Feifei Zhou","doi":"10.3389/fbioe.2025.1529545","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to develop machine learning models to predict neurological outcomes in patients with degenerative cervical myelopathy (DCM) after surgical decompression and identify key factors that contribute to a better outcome, providing a reference for patient consultation and surgical decision-making.</p><p><strong>Methods: </strong>This retrospective study reviewed 1,895 patients who underwent cervical decompression surgery for DCM at Peking University Third Hospital from 2011 to 2020, with 672 patients included in the final analysis. Five machine learning methods, namely, linear regression (LR), support vector machines (SVM), random forest (RF), XGBoost, and Light Gradient Boosting Machine (LightGBM), were used to predict whether patients achieved the minimal clinically important difference (MCID) in the improvement in the Japanese Orthopedic Association (JOA) score, which was based on basic information, symptoms, physical examination signs, intramedullary high signals on T2-weighted (T2WI) magnetic resonance imaging (MRI), and various scale scores. After training and optimizing multiple ML algorithms, we generated a model with the highest area under the receiver operating characteristic curve (AUROC) to predict short-term outcomes following DCM surgery. We evaluated the importance of the features and created a feature-reduced model. The model's performance was assessed using an external dataset.</p><p><strong>Results: </strong>The LightGBM algorithm performed the best in predicting short-term neurological outcomes in the testing dataset, achieving an AUROC value of 0.745 and an area under the precision<i>-</i>recall curve (AUPRC) value of 0.810. The important features influencing performance in the short-term model included the preoperative JOA score, age, SF-36-GH, SF-36-BP, and SF-36-PF. The feature-reduced LightGBM model, which achieved an AUROC value of 0.734, also showed favorable performance. Moreover, the feature-reduced model showed an AUROC value of 0.785 for predicting the MCID of postoperative JOA in the external dataset, which included 58 patients from other hospitals.</p><p><strong>Conclusion: </strong>We developed models based on machine learning to predict postoperative neurological outcomes. The LightGBM model presented the best predictive power regarding the surgical outcomes of DCM patients. Feature importance analysis revealed that variables, including age, preoperative JOA score, SF-36-PF, SF-36-GH, and SF-36-BP, were essential factors in the model. The feature-reduced LightGBM model, designed for ease of application, achieved nearly the same predictive power with fewer variables.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1529545"},"PeriodicalIF":4.3000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11913819/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1529545","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: This study aimed to develop machine learning models to predict neurological outcomes in patients with degenerative cervical myelopathy (DCM) after surgical decompression and identify key factors that contribute to a better outcome, providing a reference for patient consultation and surgical decision-making.

Methods: This retrospective study reviewed 1,895 patients who underwent cervical decompression surgery for DCM at Peking University Third Hospital from 2011 to 2020, with 672 patients included in the final analysis. Five machine learning methods, namely, linear regression (LR), support vector machines (SVM), random forest (RF), XGBoost, and Light Gradient Boosting Machine (LightGBM), were used to predict whether patients achieved the minimal clinically important difference (MCID) in the improvement in the Japanese Orthopedic Association (JOA) score, which was based on basic information, symptoms, physical examination signs, intramedullary high signals on T2-weighted (T2WI) magnetic resonance imaging (MRI), and various scale scores. After training and optimizing multiple ML algorithms, we generated a model with the highest area under the receiver operating characteristic curve (AUROC) to predict short-term outcomes following DCM surgery. We evaluated the importance of the features and created a feature-reduced model. The model's performance was assessed using an external dataset.

Results: The LightGBM algorithm performed the best in predicting short-term neurological outcomes in the testing dataset, achieving an AUROC value of 0.745 and an area under the precision-recall curve (AUPRC) value of 0.810. The important features influencing performance in the short-term model included the preoperative JOA score, age, SF-36-GH, SF-36-BP, and SF-36-PF. The feature-reduced LightGBM model, which achieved an AUROC value of 0.734, also showed favorable performance. Moreover, the feature-reduced model showed an AUROC value of 0.785 for predicting the MCID of postoperative JOA in the external dataset, which included 58 patients from other hospitals.

Conclusion: We developed models based on machine learning to predict postoperative neurological outcomes. The LightGBM model presented the best predictive power regarding the surgical outcomes of DCM patients. Feature importance analysis revealed that variables, including age, preoperative JOA score, SF-36-PF, SF-36-GH, and SF-36-BP, were essential factors in the model. The feature-reduced LightGBM model, designed for ease of application, achieved nearly the same predictive power with fewer variables.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology Chemical Engineering-Bioengineering
CiteScore
8.30
自引率
5.30%
发文量
2270
审稿时长
12 weeks
期刊介绍: The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信